The latest round in the battle between retail pharmacies and pharmaceutical companies over drug pricing has produced a win for Big Pharma.
On Wednesday a California appellate court upheld a lower court ruling granting summary judgment to the pharma companies in an antitrust suit brought by 15 retail pharmacies in the state. The court agreed that the plaintiffs had failed to show that the pharmaceutical companies conspired to charge higher prices on their products in the United States compared to prices they charged in Canada.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
